Nadav Kidron
2014
In 2014, Nadav Kidron earned a total compensation of $803.8K as President and CEO and director at Oramed Pharmaceuticals, a 196% increase compared to previous year.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Option Awards | $390,696 |
| Salary | $261,338 |
| Other | $31,770 |
| Total | $803,804 |
Kidron received $390.7K in option awards, accounting for 49% of the total pay in 2014.
Kidron also received $120K in bonus, $261.3K in salary and $31.8K in other compensation.
Rankings
In 2014, Nadav Kidron's compensation ranked 8,502nd out of 13,032 executives tracked by ExecPay. In other words, Kidron earned more than 34.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,502 out of 13,032 | 35th |
Division Manufacturing | 3,159 out of 4,965 | 36th |
Major group Chemicals And Allied Products | 1,068 out of 1,690 | 37th |
Industry group Drugs | 845 out of 1,369 | 38th |
Industry Pharmaceutical Preparations | 653 out of 1,042 | 37th |
Source: SEC filing on July 31, 2017.
Kidron's colleagues
We found three more compensation records of executives who worked with Nadav Kidron at Oramed Pharmaceuticals in 2014.